Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical study
The manifestation of acute hepatotoxicity caused by 5-fluorouracil could be characterized by asymptomatic elevations of liver enzymes, hepatic steatosis and fuminant hepatitis. Natural antioxidants have potential as excellent treatment strategy against diseases and drug-induced toxicities. This stud...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2020-12-01
|
Series: | Trends in Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://tips.sums.ac.ir/article_47251_7d188cfa203978a9d510db6fb450362f.pdf |
id |
doaj-6abd9272c7084367986de9c066402ae7 |
---|---|
record_format |
Article |
spelling |
doaj-6abd9272c7084367986de9c066402ae72021-07-14T06:32:49ZengShiraz University of Medical SciencesTrends in Pharmaceutical Sciences2423-56522020-12-016426327010.30476/tips.2021.87868.106547251Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical studyElias Adikwu0Nelson Ebinyo1Clara Clara Adogbo Ejovwoke2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Niger Delta University, NigeriaDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Niger Delta University, NigeriaDepartment of Biochemistry, Faculty of Science, Madonna University NigeriaThe manifestation of acute hepatotoxicity caused by 5-fluorouracil could be characterized by asymptomatic elevations of liver enzymes, hepatic steatosis and fuminant hepatitis. Natural antioxidants have potential as excellent treatment strategy against diseases and drug-induced toxicities. This study assessed the potential of resveratrol (RSV) to abrogate the hepatotoxic effect of 5-FU in rats. Forty adult male albino rats (240g± 20g) were randomized and orally supplemented with RSV (10, 20 and 40 mg/kg/day) prior to the administration of 5-FU (20mg/kg/day) intraperitoneally for 5 days. On day 6, after weighing, the rats were anesthetized, blood samples were collected and centrifuged and sera obtianed. Liver tissues were harvested and weighed. Sera and liver samples were evaluated for biochemical parameters. Liver tissues were assessed for histology. Body weight was significantly (p <0.05) decreased where as liver weight was significantly (p <0.01) increased in 5-FU administered rats in relation to control. Serum and liver lactate dehydrogenase, aminotransferases (AST), alkaline phosphatase, gamma-glutamyl transferase, total bilirubin, conjugated bilirubin and malondialdehyde levels were significantly (p <0.001) increased in 5FU-administered rats in relation to control. Liver glutathione peroxidase, catalase, glutathione and superoxide dismutase levels were significantly (p <0.001) decreased in 5-FU administered rats in relation to control. The liver of 5-FU administered rats showed necrosis and steatosis. The hepatotoxic effect of 5-FU was abrogated in a dose-related fashion in RSV 10 mg/kg (p <0.05), 20mg/kg (p <0.01), and RSV 40mg/kg (p <0.001) supplemented rats in relation to 5-FU. RVS may be clinically effective against 5-FU-induced hepatotoxicity.https://tips.sums.ac.ir/article_47251_7d188cfa203978a9d510db6fb450362f.pdf5-fluorourallivertoxicityresveratrolmitigationrat |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elias Adikwu Nelson Ebinyo Clara Clara Adogbo Ejovwoke |
spellingShingle |
Elias Adikwu Nelson Ebinyo Clara Clara Adogbo Ejovwoke Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical study Trends in Pharmaceutical Sciences 5-fluoroural liver toxicity resveratrol mitigation rat |
author_facet |
Elias Adikwu Nelson Ebinyo Clara Clara Adogbo Ejovwoke |
author_sort |
Elias Adikwu |
title |
Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical study |
title_short |
Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical study |
title_full |
Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical study |
title_fullStr |
Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical study |
title_full_unstemmed |
Resveratrol abrogates 5-flourouracil -induced hepatotoxicity: A preclinical study |
title_sort |
resveratrol abrogates 5-flourouracil -induced hepatotoxicity: a preclinical study |
publisher |
Shiraz University of Medical Sciences |
series |
Trends in Pharmaceutical Sciences |
issn |
2423-5652 |
publishDate |
2020-12-01 |
description |
The manifestation of acute hepatotoxicity caused by 5-fluorouracil could be characterized by asymptomatic elevations of liver enzymes, hepatic steatosis and fuminant hepatitis. Natural antioxidants have potential as excellent treatment strategy against diseases and drug-induced toxicities. This study assessed the potential of resveratrol (RSV) to abrogate the hepatotoxic effect of 5-FU in rats. Forty adult male albino rats (240g± 20g) were randomized and orally supplemented with RSV (10, 20 and 40 mg/kg/day) prior to the administration of 5-FU (20mg/kg/day) intraperitoneally for 5 days. On day 6, after weighing, the rats were anesthetized, blood samples were collected and centrifuged and sera obtianed. Liver tissues were harvested and weighed. Sera and liver samples were evaluated for biochemical parameters. Liver tissues were assessed for histology. Body weight was significantly (p <0.05) decreased where as liver weight was significantly (p <0.01) increased in 5-FU administered rats in relation to control. Serum and liver lactate dehydrogenase, aminotransferases (AST), alkaline phosphatase, gamma-glutamyl transferase, total bilirubin, conjugated bilirubin and malondialdehyde levels were significantly (p <0.001) increased in 5FU-administered rats in relation to control. Liver glutathione peroxidase, catalase, glutathione and superoxide dismutase levels were significantly (p <0.001) decreased in 5-FU administered rats in relation to control. The liver of 5-FU administered rats showed necrosis and steatosis. The hepatotoxic effect of 5-FU was abrogated in a dose-related fashion in RSV 10 mg/kg (p <0.05), 20mg/kg (p <0.01), and RSV 40mg/kg (p <0.001) supplemented rats in relation to 5-FU. RVS may be clinically effective against 5-FU-induced hepatotoxicity. |
topic |
5-fluoroural liver toxicity resveratrol mitigation rat |
url |
https://tips.sums.ac.ir/article_47251_7d188cfa203978a9d510db6fb450362f.pdf |
work_keys_str_mv |
AT eliasadikwu resveratrolabrogates5flourouracilinducedhepatotoxicityapreclinicalstudy AT nelsonebinyo resveratrolabrogates5flourouracilinducedhepatotoxicityapreclinicalstudy AT claraclaraadogboejovwoke resveratrolabrogates5flourouracilinducedhepatotoxicityapreclinicalstudy |
_version_ |
1721304047150956544 |